Skip to main content
. 2013 Mar 9;381(9869):805–816. doi: 10.1016/S0140-6736(12)61963-1

Figure 3.

Figure 3

Recurrence (A) and breast cancer mortality (B) by treatment allocation for 6846 women with ER-positive disease

Bars show SE. Recurrence rates are percentage per year (events/patient-years of follow-up). Death rates (overall rate – rate in women without recurrence) are percentage per year (SE). ATLAS=Adjuvant Tamoxifen: Longer Against Shorter.